Tomasz Charytoniuk

The effect of enterolactone on sphingolipid pathway and hepatic insulin resistance development in HepG2 cells

Tomasz Charytoniuk, Nicoletta Iłowska, Klaudia Berk et al. · Life Sciences · 2018 · 23 citations

Insulin Resistance, Metabolic Syndrome, Insulin Signaling +15

Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?

Krzysztof Drygalski, Klaudia Berk, Tomasz Charytoniuk et al. · Nutrition & Metabolism · 2017 · 21 citations · Full text

Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload State

Tomasz Charytoniuk, Ewa Harasim‐Symbor, Agnieszka Polak et al. · Anti-Cancer Agents in Medicinal Chemistry · 2018 · 17 citations

Cannabidiol – A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance

Tomasz Charytoniuk, Klaudia Sztolsztener, Ewa Harasim‐Symbor et al. · Biomedicine & Pharmacotherapy · 2021 · 17 citations · Full text

Brain Insulin, Cannabinoid Pharmacology, Insulin Signaling +20

The effect of enterolactone on liver lipid precursors of inflammation

Klaudia Berk, Krzysztof Drygalski, Ewa Harasim‐Symbor et al. · Life Sciences · 2019 · 14 citations

Inflammation, Anti-inflammatory, Hepatology +9